PURPOSE:
For the rapid assessment of the functional state of the cardiovascular system, in particular screening for coronary heart disease, during mass prophylactic examinations; additional diagnostic information during stress testing of monitoring the state of the cardiovascular system in dynamics in the treatment of cardiac patients.
DESCRIPTION:
It implements the original technology for processing biosignals in the phase space, due to which it is able to identify hidden signs of diseases. The device is simple and easy to use. Implemented in two versions for examinations in hospitals and home use.
TECHNICAL SPECIFICATIONS:
- method of registration of an electrocardiogram (EX): bipolar from the user’s fingers;
- EX voltage range: 0.03 to 5 mV;
- relative error in measuring EX in the range of 0.5 to 4 mV: ± 7%;
- relative error in measuring heart rate (in the range from 30 to 180 beats / min): ± 5%;
- testing period – 2 minutes.
- sensitivity and specificity exceed 93%.
- mean time between failures 2000 hours;
- overall dimensions: 100x70x25 mm;
- weight 0.2 kg.
ADVANTAGES:
Unlike the well-known analogues, PHASAGRAPH® allows you to determine subtle changes in the signal that carries additional diagnostic information and are not taken into account in traditional ECG diagnostics.
RESULTS OF THE RESEARCH:
Provides consistent results.
STAGE OF THE DEVELOPMENT READINESS:
Introduced into production.
TRANSFER OPPORTUNITY:
- Joint bringing to the industrial level.
- Joint production, sale, operation.
NOVELTY:
- 1 patent of Ukraine.
- 1 certificate of Ukraine.
IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,